Article
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Mar 2020
Aldea Mihaela, Hendriks Lizza, Mezquita Laura, Jovelet Cécile, Planchard David, Auclin Edouard, Remon Jordi, Howarth Karen, Benitez Jose Carlos, Gazzah Anas, Lavaud Pernelle, Naltet Charles, Lacroix Ludovic, de Kievit Frank, Morris Clive, Green Emma, Ngo-Camus Maud, Rouleau Etienne, Massard Christophe, Caramella Caroline, Friboulet Luc, Besse Benjamin
Abstract excerpt
INTRODUCTION: In patients with oncogene-addicted NSCLC and isolated central nervous system progression (iCNS), tissue biopsy is challenging, and the clinical utility of plasma liquid biopsy (i.e., circulating tumor DNA [ctDNA]) is unknown. METHODS: Patients with advanced NSCLC with known baseline genomic alteration (GA) (EGFR, ALK, BRAF, KRAS, HER2, ROS1, MET, PIK3CA, STK11, TP53) on tissue were divided into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
